Shares of Bio-Techne Corp. plunged 10.89% to $52.20 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.41% to 7,108.40 and Dow ...

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street ...

The biotechnology instruments market is growing due to personalized medicine, genomics, and molecular diagnostics.

Explore Forbes' 121 best healthcare employers for culture, featuring top U.S. health systems, insurers, and pharma leaders ranked for workplace excellence.

At analytica 2026, Bio‑Techne’s Dr. Simon Sumer highlighted how these tools cut development cycles, improve data consistency, and shift required lab skills. The changes come amid broader adoption of ...

Dr. Simon Sumer explains how AI‑driven protein design is shortening development cycles, improving screening efficiency, and ...

Minnesota-based UnitedHealth ( UNH) reported $111.7B in revenue for the quarter with ~2% YoY growth, exceeding the consensus by $2.1B, thanks mainly to its insurance segment. Meanwhile, its non-GAAP ...

Intel forecast stronger-than-expected Q2 revenue of $13.8–$14.8 billion, driven by robust demand for AI-focused server chips, ...

Lululemon Athletica shares tumbled about 12% in early trading on Thursday, as the struggling athletic apparel maker's ...

The custom antibody market is projected to grow at a CAGR of approximately 10% throughout the forecast period. This expansion is driven by increasing R&D activity, rising demand for highly specific ...